List of Excipients in API diphenhydramine hydrochloride and naproxen sodium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diphenhydramine hydrochloride and naproxen sodium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bayer HealthCare LLC | ALEVE PM | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 | ALUMINUM OXIDE | |
| Bayer HealthCare LLC | ALEVE PM | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 | CARNAUBA WAX | |
| Bayer HealthCare LLC | ALEVE PM | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 | CELLULOSE, MICROCRYSTALLINE | |
| Bayer HealthCare LLC | ALEVE PM | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 | FD&C BLUE NO. 2 | |
| Bayer HealthCare LLC | ALEVE PM | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 | HYPROMELLOSES | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for diphenhydramine hydrochloride and naproxen sodium
Excipient focus: ALUMINUM OXIDE
diphenhydramine hydrochloride and naproxen sodium drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
diphenhydramine hydrochloride and naproxen sodium drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diphenhydramine hydrochloride and naproxen sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
diphenhydramine hydrochloride and naproxen sodium drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
diphenhydramine hydrochloride and naproxen sodium drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diphenhydramine hydrochloride and naproxen sodium drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
diphenhydramine hydrochloride and naproxen sodium drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
diphenhydramine hydrochloride and naproxen sodium drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diphenhydramine hydrochloride and naproxen sodium drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diphenhydramine hydrochloride and naproxen sodium drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
diphenhydramine hydrochloride and naproxen sodium drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | diphenhydramine hydrochloride and naproxen sodium | 0280-1200 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride and naproxen sodium drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch